PLURISTEM THERAPEUTICS INC - FORM 10-K - EX-23.1 - CONSENT OF KOST FORER GABBAY & KASIERER, A MEMBER OF ERNST & YOUNG GLOBAL - September 10, 2020

Attached files

file filename
EX-4.3 - DESCRIPTION OF SECURITIES - PLURISTEM THERAPEUTICS INCf10k2020ex4-3_pluristem.htm
10-K - ANNUAL REPORT - PLURISTEM THERAPEUTICS INCf10k2020_pluristemtherap.htm
EX-32.2 - CERTIFICATION - PLURISTEM THERAPEUTICS INCf10k2020ex32-2_pluristem.htm
EX-32.1 - CERTIFICATION - PLURISTEM THERAPEUTICS INCf10k2020ex32-1_pluristem.htm
EX-31.2 - CERTIFICATION - PLURISTEM THERAPEUTICS INCf10k2020ex31-2_pluristem.htm
EX-31.1 - CERTIFICATION - PLURISTEM THERAPEUTICS INCf10k2020ex31-1_pluristem.htm
EX-21.1 - LIST OF SUBSIDIARIES OF THE COMPANY - PLURISTEM THERAPEUTICS INCf10k2020ex21-1_pluristem.htm
EX-10.20 - FINANCE CONTRACT BETWEEN THE EUROPEAN INVESTMENT BANK, AS LENDER, AND PLURISTEM - PLURISTEM THERAPEUTICS INCf10k2020ex10-20_pluristem.htm
EX-10.19 - AMENDED AND RESTATED EMPLOYMENT AGREEMENT BETWEEN PLURISTEM LTD. AND CHEN FRANCO - PLURISTEM THERAPEUTICS INCf10k2020ex10-19_pluristem.htm
EX-10.18 - AMENDED AND RESTATED EMPLOYMENT AGREEMENT BETWEEN PLURISTEM LTD. AND YAKY YANAY - PLURISTEM THERAPEUTICS INCf10k2020ex10-18_pluristem.htm
EX-10.17 - AMENDED AND RESTATED CONSULTING AGREEMENT BETWEEN PLURISTEM LTD. AND ROSE HIGH T - PLURISTEM THERAPEUTICS INCf10k2020ex10-17_pluristem.htm
EX-10.8 - SUMMARY OF DIRECTORS' ONGOING COMPENSATION - PLURISTEM THERAPEUTICS INCf10k2020ex10-8_pluristem.htm
EX-3.4 - AMENDED AND RESTATED BY-LAWS AS AMENDED ON SEPTEMBER 10, 2020 (MARKED) - PLURISTEM THERAPEUTICS INCf10k2020ex3-4_pluristem.htm
EX-3.3 - AMENDED AND RESTATED BY-LAWS AS AMENDED ON SEPTEMBER 10, 2020 - PLURISTEM THERAPEUTICS INCf10k2020ex3-3_pluristem.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Statement on Form S-3 (Registration No. 333-239890) and in the Registration Statements on Form S-8  (Registration No. 333-248685, 333-248686 333-229535, 333-222888, 333-217770, 333-212299, 333-206848, 333-196537, 333-173777 and 333-162577) pertaining to the Amended and Restated 2005 Stock Option Plan and the 2016 Equity Compensation Plan of Pluristem Therapeutics Inc. of our reports dated September 10, 2020, with respect to the consolidated financial statements of Pluristem Therapeutics Inc., included in this Annual Report (Form 10-K) for the year ended June 30, 2020.

  

  /s/ Kost Forer Gabbay & Kasierer
Tel Aviv, Israel Kost Forer Gabbay & Kasierer
September 10, 2020 A Member of Ernst & Young Global

 

 

 

PLURISTEM THERAPEUTICS INC Reports